Question explored with the scientific record
Is the covid vaccine causing the rise in turbo cancers
The short version: the evidence for a causal link between COVID-19 vaccination and a rise in "turbo cancers" is thin, mixed, and does not meet the burden of proof.
The largest and most relevant study retrieved is a 2025 South Korean cohort of the entire national population [2]. It found that one year after vaccination, the risk of overall cancer was not elevated (hazard ratio 1.01, p=0.803). However, it did find a statistically significant increase in pancreatic cancer (HR 2.25, p<0.001) and gastric cancer (HR 1.23, p=0.041), while leukemia risk was lower (HR 0.56, p=0.02). The authors themselves note these are associations needing causal investigation, not proof [2]. A single case report from 2025 found a possible host-vector spike sequence integration in a 31-year-old woman with aggressive bladder cancer after Moderna vaccination, but this is a single case, not population-level evidence [11]. Another case series of five patients reported cancers appearing days to months after vaccination, but it had no control group and relied on traditional Chinese medicine energy-deficiency theory, not standard epidemiology [9].
The rest of the retrieved evidence does not address the "turbo cancer" question. Several studies focus on lymphadenopathy (swollen lymph nodes) after vaccination, which is a known, temporary immune reaction that can mimic cancer on scans but is not cancer itself [3][5][7]. Other studies examine vaccine efficacy or safety in people who already have cancer [1][6][8], or look at unrelated conditions like herpes zoster [4] or psychiatric events [10]. None of these test whether vaccination causes new, aggressive cancers.
The mechanism that could plausibly link vaccination to cancer—such as the spike protein disrupting the colloidal stability of blood, or genomic integration—is documented in isolated cases but has not been tested in a large, controlled trial. The burden of proof remains unmet. The largest population study shows no overall cancer increase, but signals for specific cancers that warrant further investigation.
My call: the evidence does not support the claim that COVID-19 vaccination is causing a rise in "turbo cancers." Confidence: low, because the largest study shows no overall effect but does flag specific signals that have not been causally investigated.
Sources used 11
-
COVID-19 Infection After Different Combinations of Vaccines in Patients with Solid Tumors
This study evaluates the incidence of COVID-19 infection in cancer patients after receiving different combinations of COVID-19 vaccines, revealing similar efficacy across vaccine types but highlighting a significant time from vaccination to infection in patients undergoing cytot…
DOI: 10.14744/ejmi.2023.31704 -
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
A large population-based retrospective cohort study in South Korea using national health insurance data to estimate cancer risk one year after COVID-19 vaccination, finding associations with increased risks for six cancer types that vary by vaccine type, sex, and age, while noti…
DOI: 10.1186/s40364-025-00831-w -
Computed Tomography Imaging of COVID-19 Vaccination–related Axillary Lymphadenopathy: Updated Review of Literature
This systematic review synthesizes evidence that COVID-19 vaccination frequently causes ipsilateral axillary lymphadenopathy on chest CT (9-53% incidence) that mimics metastasis but resolves spontaneously, creating diagnostic challenges in cancer patients undergoing surveillance…
DOI: 10.32388/9qstn6 -
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study
This prospective study investigates the incidence of herpes zoster in cancer patients following the third dose of the SARS-CoV-2 mRNA-BNT162b2 vaccine, revealing a cumulative incidence of 2.6% and highlighting the correlation between impaired T cell counts and herpes zoster occu…
DOI: 10.1007/s10238-023-01263-2 -
Lymphadenopathy Associated with COVID-19 Vaccination Mimicking Breast Cancer Related Axillary LAP: Imaging Findings in Review of 880 Cases
This systematic review of 59 studies (880 cases) reports that COVID-19 vaccination can cause ipsilateral axillary and supraclavicular lymphadenopathy detectable on imaging from one day to two months after the first or second dose, most commonly with Pfizer-BioNTech, which can mi…
DOI: 10.32768/abc.202293329-341 -
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
A retrospective chart review of 284 solid-tumor cancer patients on immune checkpoint inhibitors who received COVID-19 vaccines found no increased risk of severe immune-related adverse events, supporting the safety of vaccination during ICI therapy.
DOI: 10.1080/21645515.2023.2207438 -
Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination
This study investigates the frequency and outcomes of MRI-detected ipsilateral axillary adenopathy following COVID-19 vaccination, finding that 29% of patients exhibited adenopathy, particularly younger individuals, with most cases resolving within 4-8 weeks post-vaccination.
DOI: 10.1007/s00330-022-08655-0 -
Vaccination Status and Effectiveness of COVID‐19 Vaccines in Patients with Prostate and Bladder Cancer
In a cross-sectional study of 249 bladder and prostate cancer patients, COVID-19 vaccination was associated with reduced infection risk, with vaccine effectiveness of 82% in bladder and 96% in prostate cancer patients.
DOI: 10.18502/bccr.v15i3.18740 -
Which Could Be the Risk Factors for Developing Cancer After Receiving The COVID-19 Vaccine?
In a five-case series, cancers appeared days-to-months after COVID-19 vaccination; the author attributes a shared TCM energy deficiency as risk factor and recommends TCM treatment, but no controls or statistics support causation.
DOI: 10.33140/ijcrt.08.01.01 -
Short-term risk of psychiatric adverse events following COVID-19 vaccination: nationwide self-controlled case series study
COVID-19 vaccination in South Korea did not elevate short-term risk for six psychiatric adverse events overall; a small increase in anxiety/nervousness and sleep disorders was observed in people without prior psychiatric history, particularly with viral-vector vaccines.
DOI: 10.1192/bjo.2025.10803 -
Genomic Integration and Molecular Dysregulation in Aggressive Stage IV Bladder Cancer Following COVID-19 mRNA Vaccination
Case of a 31-year-old woman with rapidly progressive stage IV bladder cancer within a year after Moderna vaccination, showing multi-omic dysregulation and a host-vector spike sequence integration outside a safe harbor, suggesting a plausible vaccine-associated genomic perturbati…
DOI: 10.23958/ijirms/vol10-i10/2130